PubRank

Y Itoyama

Author PubWeight™ 261.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 3.64
2 Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995 2.81
3 CSF hypovolemia vs intracranial hypotension in "spontaneous intracranial hypotension syndrome". Neurology 2003 2.79
4 Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005 2.77
5 Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004 2.76
6 Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 2001 2.51
7 Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology 2007 2.37
8 Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010 2.24
9 Impaired chemosensitivity and perception of dyspnoea in Parkinson's disease. Lancet 2000 2.17
10 Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1999 2.14
11 Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005 2.13
12 HTLV-II in patients with HTLV-I-associated myelopathy. Lancet 1991 2.04
13 Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat. Proc Natl Acad Sci U S A 1979 1.97
14 Immunocytochemical method to identify basic protein in myelin-forming oligodendrocytes of newborn rat C.N.S. J Neurocytol 1978 1.94
15 Neuromyelitis optica preceded by hyperCKemia episode. Neurology 2010 1.94
16 Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 1997 1.91
17 Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 2005 1.79
18 Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation. Proc Natl Acad Sci U S A 1978 1.74
19 Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998 1.62
20 Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 1994 1.53
21 Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imaging studies in 5 cases. Arch Neurol 2001 1.51
22 Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons. Neuroreport 2002 1.46
23 Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 2008 1.44
24 In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993 1.43
25 Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008 1.41
26 Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1999 1.41
27 Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies. J Neurol 1999 1.41
28 CSF tau protein: a new prognostic marker for Guillain-Barré syndrome. Neurology 2006 1.40
29 Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein. J Thorac Cardiovasc Surg 2001 1.40
30 Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1994 1.38
31 Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007 1.37
32 Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991 1.37
33 A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology 2009 1.32
34 Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke 1995 1.32
35 Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 1996 1.32
36 Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006 1.31
37 Mild ALS in Japan associated with novel SOD mutation. Nat Genet 1993 1.31
38 Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 1997 1.28
39 Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009 1.28
40 Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol 1982 1.23
41 Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann Neurol 1980 1.23
42 "Neuro-sweet disease": benign recurrent encephalitis with neutrophilic dermatosis. Arch Neurol 1999 1.21
43 Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology 2004 1.20
44 Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol 1992 1.18
45 Immunocytochemical localization of P0 protein in Golgi complex membranes and myelin of developing rat Schwann cells. J Cell Biol 1981 1.18
46 New therapeutic possibility of blocking cytokine-induced neutrophil chemoattractant on transient ischemic brain damage in rats. Brain Res 1997 1.17
47 Molecular cloning of mouse ganglioside sialidase and its increased expression in Neuro2a cell differentiation. J Biol Chem 2000 1.16
48 Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system. Ann Neurol 1980 1.13
49 Increased production of beta-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem 2000 1.10
50 Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype. Neurology 2003 1.10
51 A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis. Mult Scler 2012 1.10
52 Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study. Neurology 2011 1.09
53 Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res 1999 1.09
54 Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett 1995 1.08
55 Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 2008 1.07
56 Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch Ophthalmol 1997 1.06
57 Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. Neuroimage 2009 1.06
58 Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci 1998 1.06
59 Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease. Arch Neurol 2001 1.05
60 Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 1983 1.03
61 Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling. J Neuroimmunol 2001 1.03
62 Progressive expression of immunomolecules on activated microglia and invading leukocytes following focal cerebral ischemia in the rat. Brain Res 1996 1.03
63 Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J Immunol 1993 1.02
64 Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 2009 1.01
65 Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 1998 1.01
66 Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: diagnostic value for progressive multifocal leukoencephalopathy. Arch Virol 1998 1.01
67 Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. J Immunol 1992 1.00
68 Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002 0.98
69 Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet 1996 0.98
70 Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci 1994 0.98
71 Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 1991 0.97
72 Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res 1994 0.96
73 Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med 1994 0.96
74 Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol 1985 0.96
75 Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data. J Neurol Sci 1988 0.96
76 Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 2007 0.96
77 P2 protein in oligodendrocytes and myelin of the rabbit central nervous system. J Neurochem 1983 0.95
78 Ophthalmological findings in patients with spinocerebellar ataxia type 1 are not correlated with neurological anticipation. Graefes Arch Clin Exp Ophthalmol 2001 0.95
79 CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome. Muscle Nerve 2009 0.95
80 Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke 1995 0.94
81 Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010 0.94
82 Immunohistochemical localization of the low molecular weight stress protein HSP27 following focal cerebral ischemia in the rat. Brain Res 1995 0.94
83 Apoptosis of motor neurons with induction of caspases in the spinal cord after ischemia. Stroke 1998 0.93
84 Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 1997 0.93
85 Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis. J Neuroimmunol 1983 0.92
86 Familial juvenile neuronal storage disease. New disease or variant of juvenile lipidosis? Arch Neurol 1978 0.92
87 Glycine response in acutely dissociated ventromedial hypothalamic neuron of the rat: new approach with gramicidin perforated patch-clamp technique. J Neurophysiol 1994 0.92
88 [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version]. No To Shinkei 2001 0.91
89 Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001 0.91
90 Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. Eur J Pharmacol 1995 0.91
91 Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 2004 0.90
92 Experimental allergic encephalomyelitis in the Lewis rat. A model of predictable relapse by cyclophosphamide. J Neurol Sci 1987 0.90
93 Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke 1998 0.89
94 Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg 1999 0.89
95 Differential expression of three sialidase genes in rat development. Biochem Biophys Res Commun 2001 0.89
96 [Regrowth patterns of glioma--cases of glioma regrew away from the original tumor]. Gan No Rinsho 1989 0.89
97 Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals. J Neuroimmunol 1991 0.89
98 Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan. Neurology 2000 0.89
99 [A case of biopsy-proven sarcoid meningoencephalitis presented with hallucination, nominal aphasia and dementia]. Rinsho Shinkeigaku 1995 0.89
100 Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens. J Clin Microbiol 1992 0.88
101 A reproducible assay of polymerase chain reaction to detect trinucleotide repeat expansion of Huntington's disease and senile chorea. Neurol Res 1996 0.88
102 Immunocytochemical study of P0 glycoprotein, P1 and P2 basic proteins, and myelin-associated glycoprotein (MAG) in lesions of idiopathic polyneuritis. Neuropathol Appl Neurobiol 1982 0.88
103 Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging 2000 0.88
104 High CSF neurofilament heavy chain levels in neuromyelitis optica. Neurology 2007 0.88
105 A novel two-base mutation in the Cu/Zn superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett 1996 0.88
106 The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients. Ann Neurol 1996 0.88
107 An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 2005 0.88
108 Cyclin D1 and Cdk4 protein induction in motor neurons after transient spinal cord ischemia in rabbits. Stroke 2000 0.88
109 Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse. Eur J Pharm Sci 2001 0.88
110 Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci 1996 0.87
111 Expression of tumor necrosis factor-alpha in muscles of polymyositis. J Neurol Sci 1997 0.87
112 A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese. Tissue Antigens 1991 0.87
113 Metastatic angiosarcoma of the brain. Surg Neurol 1991 0.86
114 Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 1995 0.86
115 Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial amyotrophic lateral sclerosis with the homozygous mutation. Neurosci Lett 2001 0.86
116 Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci 1999 0.86
117 Migration of a dissected peritoneal shunt catheter into the scrotum. Brain Dev 1984 0.86
118 TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts. J Immunol 1994 0.86
119 Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neuronal injury. Neuroscience 1995 0.86
120 Clinical features of chromosome 16q22.1 linked autosomal dominant cerebellar ataxia in Japanese. Neurology 2006 0.86
121 Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles. Acta Neuropathol 2003 0.85
122 Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method. J Neuroimmunol 2004 0.85
123 Immunohistochemical localization of superoxide dismutase in the hippocampus following ischemia in a gerbil model of ischemic tolerance. J Cereb Blood Flow Metab 1995 0.85
124 Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE). J Neuroimmunol 1982 0.85
125 Loss of bag-1 immunoreactivity in rat brain after transient middle cerebral artery occlusion. Brain Res 2000 0.85
126 Hypernatremic myopathy. J Neurol Sci 1994 0.84
127 Localization of nerve growth factor, trkA and P75 immunoreactivity in the hippocampal formation and basal forebrain of adult rats. Neuroscience 1998 0.84
128 Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP. J Neuroimmunol 1991 0.84
129 Graded expression of immunomolecules on activated microglia in the hippocampus following ischemia in a rat model of ischemic tolerance. Brain Res 1995 0.84
130 Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J Neurol Sci 1992 0.84
131 Pro-apoptotic effects of tau mutations in chromosome 17 frontotemporal dementia and parkinsonism. Neuroreport 2000 0.84
132 Atypical multiple sclerosis with concentric or lamellar demyelinated lesions: two Japanese patients studied post mortem. Ann Neurol 1985 0.83
133 Embryonic genes expressed in Alzheimer's disease brains. Neurosci Lett 1996 0.83
134 Astroglial and microglial reactions in the gerbil hippocampus with induced ischemic tolerance. Brain Res 1994 0.83
135 Expression of microglial response factor-1 in microglia and macrophages following cerebral ischemia in the rat. Brain Res 2000 0.83
136 Maternal anticipation of DRPLA. Hum Mol Genet 1994 0.83
137 Neuroprotective effect of riluzole in MPTP-treated mice. Brain Res 2001 0.83
138 Mitotic and meiotic stability of the CAG repeat in the X-linked spinal and bulbar muscular atrophy gene. Clin Genet 1996 0.82
139 Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 2006 0.82
140 A presenilin-1 mutation in a Japanese family with Alzheimer's disease and distinctive abnormalities on cranial MRI. Neurology 1997 0.82
141 Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases. J Neurol Neurosurg Psychiatry 1998 0.82
142 Age-related changes in bindings of second messengers in the rat brain. Brain Res 1995 0.81
143 Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy. J Neurol 1976 0.81
144 Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain. Neurosci Lett 1997 0.81
145 Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci 1991 0.81
146 Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn superoxide dismutase gene. Neurology 1995 0.81
147 An immunohistochemical study of heat shock protein-27 in the hippocampus in a gerbil model of cerebral ischemia and ischemic tolerance. Neuroscience 1995 0.81
148 Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998 0.81
149 Protective effects of heme oxygenase-1 against oxidant-induced injury in the cultured human tracheal epithelium. Am J Respir Cell Mol Biol 1999 0.81
150 Macular degeneration associated with aberrant expansion of trinucleotide repeat of the SCA7 gene in 2 Japanese families. Arch Ophthalmol 2000 0.81
151 [Light and electron microscopy of microcystic meningioma. Case report]. Neurol Med Chir (Tokyo) 1987 0.80
152 Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study. Cephalalgia 2002 0.80
153 PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci 1996 0.80
154 Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion. Brain Res 1999 0.80
155 A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutat 1997 0.80
156 High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan. J Neurol Sci 2000 0.80
157 Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia. Exp Neurol 1998 0.80
158 An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat. Brain Res 1994 0.80
159 Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci Lett 1999 0.80
160 Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil. J Neurol Sci 1995 0.80
161 Calcium deposits in the thalamus following repeated cerebral ischemia and long-term survival in the gerbil. Brain Res Bull 1995 0.80
162 Familial myopathy with scapulohumeral distribution, rigid spine, cardiopathy and mitochondrial abnormality. J Neurol 1989 0.80
163 Dissociative expression of adenoviral-mediated E. coli LacZ gene between ischemic and reperfused rat brains. Neurosci Lett 1997 0.80
164 A case of delayed encephalopathy after carbon monoxide poisoning longitudinally monitored by diffusion tensor imaging. AJNR Am J Neuroradiol 2011 0.79
165 Analysis of spinocerebellar ataxia type 2 in Gunma Prefecture in Japan: CAG trinucleotide expansion and clinical characteristics. J Neurol Sci 1998 0.79
166 Reduction of ischemic brain injury by anti-P-selectin monoclonal antibody after permanent middle cerebral artery occlusion in rat. Neurol Res 1999 0.79
167 Therapeutic efficacy of transcranial magnetic stimulation for hereditary spinocerebellar degeneration. Tohoku J Exp Med 1999 0.79
168 Activated T cells in HTLV-I-associated myelopathy: autologous mixed lymphocyte reaction. Ann Neurol 1989 0.79
169 Expression of angiogenic factors in rabbit spinal cord after transient ischaemia. Neuropathol Appl Neurobiol 1999 0.79
170 Facilitated recovery from postischemic suppression of protein synthesis in the gerbil brain with ischemic tolerance. Brain Res Bull 1995 0.79
171 Induction of glial cell line-derived neurotrophic factor and c-ret porto-oncogene-like immunoreactivity in rabbit spinal cord after transient ischemia. Neurosci Lett 1999 0.79
172 Lymphocyte function in myasthenia gravis. J Neurol Neurosurg Psychiatry 1979 0.79
173 Early immunohistochemical changes of microtubule based motor proteins in gerbil hippocampus after transient ischemia. Brain Res 1995 0.79
174 Temporal profile of nerve growth factor-like immunoreactivity after transient focal cerebral ischemia in rats. Brain Res 1996 0.79
175 DNA single-strand breaks in postischemic gerbil brain detected by in situ nick translation procedure. Neurosci Lett 1995 0.79
176 T and B lymphocytes in myasthenia gravis. Clin Exp Immunol 1979 0.79
177 Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease. J Neurol Sci 1996 0.79
178 Ventral root avulsion leads to downregulation of GluR2 subunit in spinal motoneurons in adult rats. Neuroscience 2003 0.79
179 Glycyrrhizin increases survival of mice with herpes simplex encephalitis. Acta Virol 2001 0.79
180 Anti-P-selectin antibody attenuates rat brain ischemic injury. Neurosci Lett 1999 0.79
181 Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice. Metab Brain Dis 2002 0.79
182 Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography. J Neurol Sci 1996 0.78
183 Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Life Sci 1997 0.78
184 Decrease in multiple sclerosis with acute transverse myelitis in Japan. Tohoku J Exp Med 1999 0.78
185 Isolation of an ischemia-induced gene and early disturbance of mitochondrial DNA expression after transient forebrain ischemia. Adv Neurol 1996 0.78
186 A novel point mutation in the Cu/Zn superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995 0.78
187 Post-ischemic changes of [3H]glycine binding in the gerbil brain after cerebral ischemia. Eur J Pharmacol 1995 0.78
188 [A case of Ki-1 lymphoma-associated eosinophilic polymyositis]. Rinsho Shinkeigaku 1997 0.78
189 Histamine depletion in brain caused by treatment with (S)alpha-fluoromethylhistidine enhances ischemic damage of gerbil hippocampal CA2 neurons. Brain Res 1994 0.78
190 Neuro-Behçet's disease presenting initially as mesiotemporal lesions mimicking herpes simplex encephalitis. Eur J Neurol 2005 0.78
191 Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography. J Neurol Sci 1997 0.78
192 [Transient prosopagnosia and lasting topographical disorientation after the total removal of a right occipital arteriovenous malformation]. Rinsho Shinkeigaku 1996 0.78
193 Successful immunocytochemical localization of myelin components in paraffin sections of human nervous tissue with preliminary observations on multiple sclerosis and metachromatic leukodystrophy lesions. Trans Am Neurol Assoc 1978 0.78
194 Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol 2001 0.78
195 Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP. J Neuroimmunol 1992 0.78
196 Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease. J Neurosci Res 1997 0.78
197 Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan. Neurology 1995 0.78
198 Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurol Sci 1998 0.78
199 Molecular analyses of the Cu/Zn superoxide dismutase gene in patients with familial amyotrophic lateral sclerosis (ALS) in Japan. Cell Mol Neurobiol 1998 0.78
200 Effects of chronic treatment with a cyclic AMP-selective phosphodiesterase inhibitor, rolipram, on excitatory amino acid neurotransmission systems in young and aged rat brains. J Neural Transm (Vienna) 1997 0.78
201 [Recurrent unilateral painful oculomotor nerve palsy with an ipsilateral posterior ethmoidal mucocele]. Rinsho Shinkeigaku 1989 0.78
202 Postischemic changes in the immunophilin FKBP12 in the rat brain. Brain Res Mol Brain Res 2000 0.78
203 Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration. J Neurol Neurosurg Psychiatry 2002 0.78
204 Clinical and physiological significance of abnormally prolonged central motor conduction time in HAM/TSP. J Neurol Sci 2001 0.78
205 Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy. J Neurol Sci 1988 0.78
206 Ruptured distal accessory anterior cerebral artery aneurysm: case report. Neurosurgery 1997 0.78
207 Brain-gut induction of heat shock protein (HSP) 70 mRNA by psychophysiological stress in rats. Brain Res 1997 0.77
208 Endothelin receptors in ischemic rat brain and Alzheimer brain. J Cardiovasc Pharmacol 1995 0.77
209 Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands. Mult Scler 2007 0.77
210 Pure anarthria with predominantly sequencing errors in phoneme articulation: a case report. Cortex 2001 0.77
211 Involvement of cytokine production in pathogenesis of transient cerebral ischemic damage. Keio J Med 1996 0.77
212 Rice bran hemicellulose increases the peripheral blood lymphocytes in rats. Life Sci 1993 0.77
213 [Herpetic brainstem encephalitis--a case report]. Rinsho Shinkeigaku 1985 0.77
214 Psychophysiological stress induces heat shock cognate protein (HSC) 70 mRNA in the cerebral cortex and stomach of rats. Brain Res 1995 0.77
215 DNA fragmentation precedes aberrant expression of cell cycle-related protein in rat brain after MCA occlusion. Neurol Res 1999 0.77
216 Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats. J Neural Transm (Vienna) 2000 0.77
217 In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain. Brain Res 1997 0.77
218 Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol Res 2002 0.77
219 Alterations in [3H]L-N(G)-nitroarginine binding in brain after transient global or transient focal ischemia in gerbils and rats. Eur J Pharmacol 1998 0.77
220 Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neuroimmunol 1999 0.77
221 [Tolosa-Hunt syndrome with enlargement of optic nerve shadow on CT]. Rinsho Shinkeigaku 1986 0.77
222 [Interferon-alpha for the treatment of retinal vasculitis associated with human T-lymphotropic virus type I myelopathy (HAM)]. Nippon Ganka Gakkai Zasshi 1990 0.77
223 Immunocytochemical localization of herpes simplex virus antigen in the trigeminal ganglia of experimentally infected mice. J Neurol Sci 1984 0.77
224 Clustering of three cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan. Acta Neurol Scand 1991 0.77
225 Reduction of CAG expansions in cerebellar cortex and spinal cord of DRPLA. Clin Genet 1996 0.77
226 Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance. Brain Res 1994 0.77
227 A change of P-selectin immunoreactivity in rat brain after transient and permanent middle cerebral artery occlusion. Neurol Res 1998 0.77
228 Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients. J Neuroimmunol 2001 0.77
229 Expressions of nerve growth factor and p75 low affinity receptor after transient forebrain ischemia in gerbil hippocampal CA1 neurons. J Neurosci Res 1995 0.77
230 Complement activation as a cause of transient hypotension during plasmapheresis. Artif Organs 1998 0.77
231 Increased plasma GDNF levels in patients with chronic renal diseases. Nephrol Dial Transplant 1999 0.77
232 The protective effect of L-threo-3,4-dihydroxyphenylserine on ischemic hippocampal neuronal death in gerbils. Stroke 1994 0.77
233 Treatment-related disseminated necrotizing leukoencephalopathy with characteristic contrast enhancement of the white matter. Radiat Med 1997 0.77
234 Rapid and semiquantitative analysis of HSP72 and HSC73 heat shock mRNAs by mimic RT-PCR. Brain Res 1995 0.77
235 [A case of limbic encephalitis associated with breast cancer developed in an HTLV-1 carrier]. Rinsho Shinkeigaku 1999 0.77
236 Modulation of dendritic cell development by immunoglobulin G in control subjects and multiple sclerosis patients. Clin Exp Immunol 2007 0.77
237 Expression of OX40 and OX40 ligand (gp34) in the normal and myasthenic thymus. Acta Neurol Scand 2000 0.77
238 Postischemic expression of P-selectin immunoreactivity in rat brain. Neurosci Lett 1997 0.77
239 Different age-related changes in NMDA and glycine receptors in the rat brain. Environ Toxicol Pharmacol 1996 0.76
240 Inductions of Cu/Zn superoxide dismutase- and nitric oxide synthase-like immunoreactivities in rabbit spinal cord after transient ischemia. Brain Res 1996 0.76
241 Regional age-related alterations in cholinergic and GABAergic receptors in the rat brain. Mech Ageing Dev 1996 0.76
242 Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci Lett 1996 0.76
243 A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult Scler 2002 0.76
244 Progressive multifocal leukoencephalopathy in a patient with acquired immunodeficiency syndrome (AIDS) manifesting Gerstmann's syndrome. Tohoku J Exp Med 1998 0.76
245 Analysis of prognostic factors in thymectomized patients with myasthenia gravis: correlation between thymic lymphoid cell subsets and postoperative clinical course. J Neurol Sci 1991 0.76
246 Stress protein inductions after brain ischemia. Cell Mol Neurobiol 1998 0.76
247 Abnormal gel-electrophoretic behavior of presenilin 1 and it's fragment. Biochem Biophys Res Commun 1996 0.76
248 Decrease in cerebellin and corticotropin-releasing hormone in the cerebellum of olivopontocerebellar atrophy and Shy-Drager syndrome. Brain Res 1995 0.76
249 Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain. Eur Neuropsychopharmacol 2000 0.76
250 Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. Neurol Res 2002 0.76
251 Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res 1998 0.76
252 Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies. J Neurol Sci 1998 0.76
253 A clinical variance in familial amyotrophic lateral sclerosis with a point mutation in Cu/Zn superoxide dismutase gene. Eur J Neurol 1995 0.76
254 Ischemic tolerance can be induced repeatedly in the gerbil hippocampal neurons. Neurosci Lett 1994 0.76
255 Expression of adenovirus-mediated E. coli lacZ gene in skeletal muscles and spinal motor neurons of transgenic mice with a mutant superoxide dismutase gene. Neurosci Lett 1998 0.76
256 Role of hippocampal serotonergic neurons in ischemic neuronal death. Behav Brain Res 1997 0.76
257 Elevated plasma level of plasminogen activator inhibitor-1 (PAI-1) in patients with relapsing-remitting multiple sclerosis. Tohoku J Exp Med 1999 0.76
258 Two consecutive fasciculation potentials having different motor unit origins are an electromyographically pathognomonic finding of ALS. Electromyogr Clin Neurophysiol 2000 0.76
259 A case of Marchiafava-Bignami disease with complete recovery: sequential imaging documenting improvement of callosal lesions. Tohoku J Exp Med 1997 0.76
260 Effect of rolipram on age-related changes in cyclic AMP-selective phosphodiesterase in the rat brain: an autoradiographic study. Methods Find Exp Clin Pharmacol 1998 0.76
261 [Epidemiology and clinical features of optic-spinal form multiple sclerosis in Japan]. No To Shinkei 2001 0.75
262 Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 2000 0.75
263 HAM/TSP attributable to blood transfusion. J Neurol Neurosurg Psychiatry 1992 0.75
264 Alteration of neurotensin receptors in MPTP-treated mice. Peptides 1999 0.75
265 The role of locally retained antigens in chronic relapsing experimental allergic encephalomyelitis in guinea pigs. Prog Clin Biol Res 1984 0.75
266 ATP responses in the embryo chick ciliary ganglion cells. Neuroscience 1995 0.75
267 An immunohistochemical observation of manganese superoxide dismutase in rat substantia nigra after occlusion of middle cerebral artery. Neurosci Lett 1994 0.75
268 Upregulation of Bcl-2 protein in the myasthenic thymus. Ann Neurol 1996 0.75
269 [Pathogenesis of HIV-1-associated-neurologic diseases]. Nihon Rinsho 1997 0.75
270 Effects of vinconate on age-related alterations in [3H]MK-801, [3H]glycine, sodium-dependent D-[3H]aspartate, [3H]FK-506 and [3H]PN200-110 binding in rats. Mech Ageing Dev 1997 0.75
271 Age-related changes in [3H]nimodipine and [3H]rolipram binding in the rat brain. J Pharm Pharmacol 1997 0.75
272 Procalcitonin might help in discrimination between meningeal neuro-Behçet disease and bacterial meningitis. Neurology 2009 0.75
273 [Isolated fourth ventricle simulating the Guillain-Barré's syndrome]. No Shinkei Geka 1985 0.75
274 [Clinical and electrophysiological analysis of Fisher's syndrome]. Rinsho Shinkeigaku 1986 0.75
275 [A family with oculopharyngeal muscular dystrophy with (GCG)9 expansion in which a sister had neck as well as proximal and her brother proximal lower limb muscle weakness]. Rinsho Shinkeigaku 2000 0.75
276 [A case of Tolosa-Hunt syndrome starting from abducens nerve palsy alone]. Rinsho Shinkeigaku 2001 0.75
277 The familial parkinsonism locus on chromosome 4 and idiopathic Parkinson's disease in Japan. J Neurol Neurosurg Psychiatry 1998 0.75
278 A Japanese family with Machado-Joseph disease characterized by initial emaciation and myoclonus. Eur J Neurol 1995 0.75
279 [McArdle's disease. Clinical, electromyographic and histological studies of the 1st case reported in Japan]. Rinsho Shinkeigaku 1975 0.75
280 [Endoneurial deposition of immunoglobulins in cases of plasma cell dyscrasia associated with polyneuropathy, edema and pigmentation (author's transl)]. Rinsho Shinkeigaku 1982 0.75
281 Generation of CD4+ blastoid T cells in recipients of BP/IFA-sensitized spleen cells. Cell Immunol 1990 0.75
282 Effects of vinconate on neurotransmitter receptor systems in aged rat brain. Environ Toxicol Pharmacol 1996 0.75
283 DNA single-strand breaks are increased in muscle diseases with rimmed vacuoles. Acta Neuropathol 2000 0.75
284 [Neuro-Behçet's syndrome with contrast enhancement on brain computed tomography]. Rinsho Shinkeigaku 1986 0.75
285 Induction of Jun-like immunoreactivity in astrocytes in gerbil hippocampus with ischemic tolerance. Neurosci Lett 1995 0.75
286 [Hand motor cortical area reorganization following cerebral infarction evaluated with functional MRI, near infrared spectroscopic imaging, and transcranial magnetic stimulation]. No To Shinkei 2001 0.75
287 Relationship between surface marker expression and encephalitogenic potency of BP-cultured lymphocytes. Cell Immunol 1988 0.75
288 [Successful treatment of emotional disturbances following non-herpetic limbic encephalitis by serotonergic agents. A case report]. Rinsho Shinkeigaku 2001 0.75
289 Effects of cerebral ischemia on dopamine receptors in the gerbil striatum. Eur J Pharmacol 1996 0.75
290 [Scalp recorded P13 and spinal recorded N13 in short latency somatosensory evoked potentials]. No To Shinkei 1988 0.75
291 Decrement of N20 amplitude of the median nerve somatosensory evoked potential in Creutzfeldt-Jakob disease patients. J Clin Neurophysiol 2001 0.75
292 [A case of Wernicke-Korsakoff syndrome with dramatic improvement in consciousness immediately after intravenous infusion of thiamine]. No To Shinkei 2000 0.75
293 Acquired intracerebral toxoplasmosis presented as calcified mass lesions. Neurol Med Chir (Tokyo) 1985 0.75
294 [Lazarus' sign and respiratory-like movement in a patient with brain death]. No To Shinkei 1988 0.75
295 [A family of early childhood-onset Charcot-Marie-Tooth disease type 2]. Rinsho Shinkeigaku 2001 0.75
296 [A case of primary Sjögren's syndrome with CNS disease mimicking chronic progressive multiple sclerosis]. Rinsho Shinkeigaku 1998 0.75
297 Neurocutaneous melanosis with intracranial malignant melanoma in an adult: a case report. No Shinkei Geka 1997 0.75
298 Allolymphocytotoxic antibodies in sera from HTLV-I-associated myelopathy/tropical spastic paraparesis patients--putative anti-HLA antibodies. J Neurol Sci 1994 0.75
299 Enhanced proliferative response of myasthenic thymus cells in mixed lymphocyte reaction. J Neurol Sci 1992 0.75
300 [Pathogenesis and the treatment of secondary syringomyelia]. No To Shinkei 1987 0.75
301 Effect of nitric oxide synthase inhibitor on age-related changes in second messenger systems and calcium channels in rats. Metab Brain Dis 1997 0.75
302 Acute epidural hematoma complicating Paget's disease of the skull. Surg Neurol 1986 0.75
303 [Dysthyroid ophthalmopathy]. No To Shinkei 1999 0.75
304 Differential diagnosis of early stage Huntington's disease from dentatorubral-pallidoluysian atrophy by DNA analysis. Eur J Neurol 1995 0.75
305 [Minimal Record of Disability in Multiple Sclerosis--its application to Japanese MS patients]. Rinsho Shinkeigaku 1984 0.75
306 Age-related changes of sodium-dependent D-[3H]aspartate and [3H]FK506 binding in rat brain. J Neural Transm (Vienna) 1997 0.75
307 Anaplastic astrocytoma with extracranial extension--case report. Neurol Med Chir (Tokyo) 1993 0.75
308 [An autopsy case of atypical Friedreich's ataxia with chronic idiopathic intestinal pseudo-obstruction]. Rinsho Shinkeigaku 2001 0.75
309 Sequential changes of [H]forskolin, [H]cyclohexyladenosine and [H]PN200-110 binding sites in the brain of 6-hydroxydopamine-lesioned rats. Acta Physiol Scand 2000 0.75
310 Generation of CD4+ blastoid T cells showing marked upregulation of CD4, class I and II MHC, and IL2 receptor molecules is required for the expression of potent encephalitogenicity. Cell Immunol 1989 0.75
311 [A juvenile case of Lambert-Eaton myasthenic syndrome with severe emaciation]. Rinsho Shinkeigaku 1997 0.75
312 Pharmacological properties of pteleprenine, a quinoline alkaloid extracted from Orixa japonica, on guinea-pig ileum and canine left atrium. J Pharm Pharmacol 1998 0.75
313 [Familial juvenile neuronal storage disease. Cherry red spots and dyssynergia cerebellaris myoclonica without dementia type (author's transl)]. Rinsho Shinkeigaku 1976 0.75
314 [A case of potassium-sensitive periodic paralysis with cardiac dysrhythmia controlled with imipramine and acetazolamide]. No To Shinkei 2001 0.75
315 Human parvovirus B19 infection in multiple sclerosis. Eur Neurol 1999 0.75
316 [Etiology and physiopathology of multiple sclerosis]. Nihon Naika Gakkai Zasshi 1998 0.75
317 [Retrovirus and neurologic diseases]. Fukuoka Igaku Zasshi 1988 0.75
318 The effect of long-term post-ischemic bifemelane hydrochloride treatment on cholinergic systems in the gerbil hippocampus. Brain Res 1996 0.75
319 Pyogenic upper cervical spinal infection as a cause of sudden-onset quadriplegia--case report. Neurol Med Chir (Tokyo) 1988 0.75
320 [Steroid-responsive diffuse cerebral white matter lesions in a case of intractable fungal meningoencephalitis]. No To Shinkei 1999 0.75
321 Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats. Neurol Res 1998 0.75
322 [Etiology and treatment of multiple sclerosis]. Nihon Naika Gakkai Zasshi 2001 0.75
323 Choroidal epithelial cyst in the cerebellopontine angle associated with trigeminal neuralgia--case report. Neurol Med Chir (Tokyo) 1989 0.75
324 [Neuromyelitis optica(Devic disease) and optic-spinal form multiple sclerosis]. No To Shinkei 2001 0.75
325 [Cerebellin in the cerebellum in spinocerebellar degeneration]. No To Shinkei 1995 0.75
326 An immunohistochemical study of parvalbumin containing interneurons in the gerbil hippocampus after cerebral ischemia. Metab Brain Dis 1994 0.75
327 [A case of multiple intracranial tuberculoma diagnosed by open brain biopsy]. Rinsho Shinkeigaku 1997 0.75
328 [Transverse myelopathy with renovascular hypertension caused by fibromuscular dysplasia]. No To Shinkei 2001 0.75
329 [Diagnosis of herpes simplex encephalitis--an application and its problem]. Rinsho Shinkeigaku 1996 0.75
330 [Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations in Japan]. Nihon Rinsho 1996 0.75
331 [Correlation between abnormal SSEP and clinicoradiological findings in cervical lesions]. No Shinkei Geka 1988 0.75
332 Immunocytochemical detection of tumor necrosis factor-alpha in infiltrating tumor cells in the cerebrospinal fluid from five patients with leptomeningeal carcinomatosis. Acta Neurol Scand 1995 0.75
333 [A case of polyneuropathy associated with increased levels of vascular endotherial growth factor (VEGF) insera]. Rinsho Shinkeigaku 2001 0.75
334 Spinal malignant fibrous histiocytoma producing cord compression--case report. Neurol Med Chir (Tokyo) 1987 0.75
335 Expressions of P-selectin- and HSP72-like immunoreactivities in rat brain after transient middle cerebral artery occlusion. Brain Res 1997 0.75
336 [Progressive cerebellar ataxia and distal amyotrophy of Charcot-Marie-Tooth type with hyperglutamataemia:two sibling cases]. Rinsho Shinkeigaku 1995 0.75
337 [A case of rhabdomyolysis with water intoxication confirmed by muscle biopsy]. No To Shinkei 2000 0.75
338 Reduction of nerve growth factor receptor immunoreactivity in ischaemic gerbil hippocampal CA1 neurons after treatment with L-threo-3,4-dihydroxyphenylserine (DOPS). Neurol Res 1994 0.75
339 [Follow-up study of myasthenia gravis: evaluation of thymectomy in 300 patients]. No To Shinkei 2001 0.75
340 Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica. Neurology 2004 0.75
341 Familial spinal arachnoiditis with secondary syringomyelia: clinical studies and MRI findings. J Neurol Sci 2000 0.75
342 Induction of heat shock protein 70 and glial fibrillary acidic protein in the postischemic gerbil hippocampus. Metab Brain Dis 1994 0.75
343 Adoptive transfer of experimental allergic encephalomyelitis with lectin-activated spleen cells. Part 2. Studies on T cell subsets and interleukin 2 production. J Neurol Sci 1986 0.75
344 Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) J Neurol Sci 1996 0.75
345 [A case of demyelinating disease showing a peculiar honeycomb-like and lamellar structure on magnetic resonance imaging]. Rinsho Shinkeigaku 1990 0.75
346 [ALS models by transgenic animals]. No To Shinkei 2001 0.75
347 Histological recovery of the hepatocytes is based on the redox system upregulation in the animal models of mutant superoxide dismutase (SOD)1-linked amyotrophic lateral sclerosis. Histol Histopathol 2006 0.75
348 Chronic relapsing experimental allergic encephalomyelitis in strain 13 guinea pigs; presence of myelin basic protein in the local tissue long after the immunization. Jpn J Exp Med 1982 0.75
349 [Craniopharyngioma in the third ventricle]. No Shinkei Geka 1988 0.75
350 Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis. Ann Neurol 1990 0.75
351 Surface phenotypes of lymphoid cells altered in the human myasthenic thymus. Neurology 1988 0.75
352 In vivo adenovirus-mediated gene transfer and expression in ischemic rabbit spinal cord. J Vasc Surg 1999 0.75
353 [Physiopathology and treatment of multiple sclerosis]. Nihon Naika Gakkai Zasshi 1997 0.75
354 [Importance of EEG and diagnostic image for diagnosis of nervous system infections]. Nihon Naika Gakkai Zasshi 1996 0.75
355 Lambert-Eaton myasthenic syndrome associated with an anterior mediastinal small cell carcinoma. J Thorac Cardiovasc Surg 2001 0.75
356 Autonomic disorders in patients with peripheral neuropathies. Funct Neurol 1987 0.75
357 [Demyelinating diseases among the Japanese--with special reference to multiple sclerosis]. Nihon Rinsho 1980 0.75
358 Increases in [3H]FK-506 and [3H]L-N(G)-nitro-arginine binding in the rat brain after nigrostriatal dopaminergic denervation. Metab Brain Dis 1999 0.75
359 [Long-term follow-up study of seventeen cases with Wilson's disease]. Rinsho Shinkeigaku 1985 0.75
360 Postpartum exacerbation of HTLV-I associated myelopathy/tropical spastic paraparesis followed by an episode of painless thyroiditis. Intern Med 1994 0.75
361 Primary central nervous system leukemia with a novel chromosomal translocation. J Neurol Sci 1997 0.75
362 Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle. Eur J Pharm Sci 1999 0.75
363 CAG repeat length and disease duration in Machado-Joseph disease: a new clinical classification. J Neurol Sci 1997 0.75
364 Minimal record of disability in multiple sclerosis--application to Japanese patients. Acta Neurol Scand Suppl 1984 0.75
365 [An autopsy case of malignant schwannoma in the brachial plexus extending into the spinal canal]. No To Shinkei 1986 0.75
366 [A case of spontaneous intracranial hypotension with a remarkable leakage and collection of CSF]. Rinsho Shinkeigaku 1999 0.75
367 Delayed type skin response to myelin basic protein in chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1983 0.75
368 Post-ischemic alterations in [3H]FK506 binding in the gerbil and rat brains. Metab Brain Dis 1998 0.75
369 Remarkable effect of anticoagulation therapy in Churg-Strauss syndrome-associated neuropathy: a case report. Eur J Neurol 2006 0.75
370 [Molecular and clinical features of SCA 7]. No To Shinkei 2001 0.75
371 Psychophysiological stress induces heat shock cognate protein 70 messenger RNA in the hippocampus of rats. Neuroscience 1999 0.75
372 Protective effect of riluzole on MPTP-induced depletion of dopamine and its metabolite content in mice. Metab Brain Dis 2000 0.75
373 [PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism]. Nihon Rinsho 1997 0.75
374 [Sinus thrombosis during CDDP and VP-16 (PE) therapy for suprasellar germ-cell tumor: case report]. No Shinkei Geka 1993 0.75
375 Ontogeny of protein kinase C in the rat hippocampus: an autoradiographic study with [3H]phorbol 12,13-dibutyrate. Brain Res 1994 0.75
376 [Dissecting aneurysm of the cervical internal carotid artery. Cervical CT scan findings and treatment--case report]. Neurol Med Chir (Tokyo) 1987 0.75
377 [A novel splice-site mutation in the STA gene in a Japanese patient with Emery-Dreifuss muscular dystrophy]. Rinsho Shinkeigaku 1999 0.75
378 Analysis of the McLeod syndrome gene in three patients with neuroacanthocytosis. J Neurol Sci 1997 0.75
379 Delayed damage of striatal interneurons after cerebral ischemia in the gerbil. Neurosci Lett 1994 0.75
380 Effect of cerebral ischemia on dopamine receptors and uptake sites in the gerbil hippocampus. Eur Neuropsychopharmacol 1997 0.75
381 A clinical trial of therapeutic electrical stimulation for amyotrophic lateral sclerosis. Tohoku J Exp Med 1995 0.75
382 [Pathogenesis of neurological disorders in AIDS]. Nihon Rinsho 1994 0.75
383 [Surgical treatment of the symptomatic carotid stenosis associated with unruptured ipsilateral intracranial aneurysm. Case report]. Neurol Med Chir (Tokyo) 1984 0.75
384 [Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated with acute optic neuritis]. Rinsho Shinkeigaku 1988 0.75
385 Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug. Jpn J Exp Med 1981 0.75
386 [Relapsing polychondritis with neurological signs similar to dentatorubropallidoluysian atrophy]. Nihon Naika Gakkai Zasshi 1988 0.75
387 Adoptive transfer of experimental allergic encephalomyelitis with lectin-activated spleen cells. J Neurol Sci 1985 0.75
388 Necessity of continuous antigenic stimulation by the locally retained antigens in chronic relapsing experimental allergic encephalomyelitis. J Neurol Sci 1984 0.75
389 [Histopathological findings of the sural nerve in chronic polyneuropathy associated with skin hyperpigmentation and dysglobulinemia--comparison with those in chronic polyneuropathy associated with IgM kappa paraproteinemia]. Rinsho Shinkeigaku 1984 0.75
390 [Clinical course and corticosteroid therapy of multiple sclerosis among Japanese patients]. Rinsho Shinkeigaku 1983 0.75
391 Effect of NG-nitro-L-arginine on age-related changes of glutamate receptor systems and immunophilin in rats. Methods Find Exp Clin Pharmacol 1997 0.75
392 Optic-spinal form of multiple sclerosis and immune-mediated myelopathy in Japan. J Neural Transm Suppl 2000 0.75
393 IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II. Int J Cancer 2001 0.75
394 Age-related effects of rolipram on [3H]quinuclidinyl benzilate and [3H]phorbol 12,13-dibutyrate binding in the rat brain. Tohoku J Exp Med 1998 0.75
395 Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Brain Res 1999 0.75
396 [A case of encephalomyeloneuritis and HTLV-I infection]. No To Shinkei 1999 0.75
397 Alteration of [3H]hemicholinium-3 binding in the post-ischaemic gerbil brain. Neuroreport 1995 0.75
398 Surface phenotypic changes of spleen cells on acquisition of encephalitogenicity. J Neuroimmunol 1987 0.75
399 Protective effects of a novel calcium antagonist with platelet-activating factor-antagonistic action, F-0401, against ischemic brain damage. Arch Int Pharmacodyn Ther 1995 0.75
400 Fibromuscular dysplasia accompanied by giant intracranial fusiform aneurysm--report of two cases. Neurol Med Chir (Tokyo) 1988 0.75
401 Post-ischaemic alteration of excitatory amino acid transport sites in the gerbil hippocampus. J Pharm Pharmacol 1997 0.75
402 A family with mild clinical manifestations of spinocerebellar ataxia type 1 (SCA1): correlation with smaller CAG repeats. Eur J Neurol 1995 0.75
403 Molecular and clinical analysis on muscle wasting in patients with spinocerebellar ataxia type 1. Muscle Nerve 1996 0.75
404 Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers. Neurology 1992 0.75
405 [Three cases with syndrome of crocodile tears: ipsilateral gusto-lacrimal reflex by study of taste stimulation]. Rinsho Shinkeigaku 1985 0.75
406 [PET study using 6-[18F]-fluorodopa in Parkinson's disease]. Nihon Rinsho 1997 0.75
407 [A case of various neurological deficits caused by multi-vitamin deficiency associated with malabsorption syndrome after pancreatomy and small bowel resection]. Rinsho Shinkeigaku 1999 0.75
408 [Delayed traumatic intracranial arterial spasm. Report of two cases with review of the literature]. Neurol Med Chir (Tokyo) 1987 0.75